Overview
Hemolytic anemias result from increased destruction of red cells or a shortened red cell lifespan, and are characterized by increased red cell destruction accompanied by compensatory bone marrow regeneration. The normal red cell lifespan of 120 days can be dramatically shortened by intrinsic or extrinsic defects.
This final lesson in the module covers the classification of hemolytic anemia by site of destruction (intravascular vs extravascular) and by mechanism (intracorpuscular vs extracorpuscular), the biochemical consequences of hemolysis, and two important examples — hereditary spherocytosis and paroxysmal nocturnal hemoglobinuria — that illustrate the laboratory approach to diagnosing hemolysis.
Learning Objectives
After this lesson you will be able to…- Define hemolytic anemia and describe its underlying pathogenesis
- Classify hemolytic anemia as intravascular/extravascular and intracorpuscular/extracorpuscular
- Explain the biochemical changes that occur during hemolysis
- Describe the laboratory diagnosis of hereditary spherocytosis including the osmotic fragility test
- Discuss the pathophysiology and diagnosis of paroxysmal nocturnal hemoglobinuria (PNH)
Clinical Story
Why This MattersA young man with recurrent episodes of jaundice and dark urine, along with a family history of gallstones at a young age, is referred to the hematology laboratory. The technologist must determine whether this represents a hereditary red cell membrane defect or an acquired hemolytic process, using the peripheral smear, osmotic fragility test, and Coombs test to guide the diagnosis and eventual splenectomy decision.
Core Concepts
The normal red cell lifespan is 120 days; in hemolysis, the marrow compensates by increasing erythropoiesis 6–8 fold, and true anemia results only when this compensation is exceeded. Hemolytic anemia is classified by site — intravascular (destruction within the circulation) or extravascular (destruction by tissue macrophages in spleen, liver, marrow, lymph nodes) — and by mechanism — intracorpuscular (intrinsic red cell defect: membrane, hemoglobin, or enzyme abnormality, usually hereditary except PNH) or extracorpuscular (normal red cells destroyed by external factors: immune, infective, mechanical, toxic, or drug-induced).
When red cells are destroyed, hemoglobin breaks down to globin (recycled to amino acids) and heme (iron recycled via transferrin; protoporphyrin converted to biliverdin, then unconjugated bilirubin). Unconjugated bilirubin is conjugated in the liver and excreted in bile, ultimately appearing as urobilinogen in urine and stercobilinogen in stool. In intravascular hemolysis, free hemoglobin binds haptoglobin; once haptoglobin is saturated, hemoglobinemia and hemoglobinuria occur, and tubular reabsorption produces hemosiderinuria — a marker of recent intravascular hemolysis.
An autosomal dominant red cell membrane disorder caused by deficiency of cytoskeletal proteins (mainly spectrin and ankyrin), producing rigid spherocytes that are trapped and destroyed in the spleen. Patients present with jaundice, gallstones, splenomegaly, and leg ulcers. Laboratory diagnosis shows mildly decreased Hb/PCV/RBC, normal MCV/MCH but increased MCHC, spherocytes on smear lacking central pallor, and an increased osmotic fragility test. A direct Coomb's test must be performed to exclude an immune cause of spherocytosis.
An acquired clonal stem cell disorder from a PIGA gene mutation causing deficiency of GPI-anchored complement defense proteins (CD55, CD59), rendering red cells abnormally sensitive to complement-mediated hemolysis, particularly at low pH. Classically presents with episodic nocturnal intravascular hemolysis and hemoglobinuria, often with thrombocytopenia, leucopenia, and unusual site thrombosis; frequently associated with aplastic anemia. The Ham (acidified serum lysis) test demonstrates this abnormal complement sensitivity, and flow cytometry for GPI-linked proteins is now the standard confirmatory test. The direct Coombs test is characteristically negative.
Laboratory Principle
Laboratory diagnosis of hemolytic anemia rests on demonstrating both increased red cell destruction (raised unconjugated bilirubin, raised LDH, raised urinary urobilinogen, reduced haptoglobin, and — in intravascular hemolysis — hemoglobinemia or hemoglobinuria) and compensatory marrow regeneration (raised reticulocyte count, polychromasia and nucleated red cells on smear, erythroid hyperplasia in the marrow). Specific tests such as the osmotic fragility test and the Ham test then narrow the diagnosis to a particular underlying mechanism.
Equipment Required
Reagents & Materials
| Reagent / Material | Concentration / Grade | Purpose | Storage |
|---|---|---|---|
| Hypotonic Saline Series | 0.1%–0.9% NaCl dilutions | Osmotic fragility testing | Room temperature, prepare fresh |
| Polyspecific AHG (Coombs) Reagent | Anti-IgG + Anti-C3d | Direct Coombs test to exclude immune hemolysis | 2–8°C |
| Fresh Complement Serum | ABO-compatible fresh serum | Ham (acidified serum lysis) test for PNH | Use fresh, same-day |
| Anti-CD55/CD59 Fluorescent Antibodies | Flow cytometry panel | Confirms GPI-anchored protein deficiency in PNH | 2–8°C, protect from light |
Step-by-Step Procedure
Measure serum bilirubin (predominantly unconjugated), LDH, and haptoglobin, and check urine for urobilinogen/hemoglobin.
Perform a reticulocyte count to confirm compensatory marrow regeneration.
Look for spherocytes, fragmented cells, target cells, or other diagnostic red cell morphology.
Rule in or out an immune cause for any spherocytosis or hemolysis identified.
Depending on findings, perform the osmotic fragility test for suspected hereditary spherocytosis, or Ham test/flow cytometry for suspected PNH.
Flow Diagram
Quality Control
Osmotic fragility testing should always include a normal control blood sample run in parallel with the patient sample to confirm the saline dilution series and technique are performing correctly before interpreting patient results.
Laboratories offering flow cytometric PNH testing should participate in specialized external quality assessment schemes for GPI-anchored protein analysis, given the technical complexity and clinical importance of accurate PNH diagnosis.
Reference Values
Normal Ranges⚠️ Reference ranges may vary between laboratories. Always apply your laboratory's established reference intervals.
Clinical Interpretation
| Finding | Possible Significance | Action / Follow-up |
|---|---|---|
| Raised unconjugated bilirubin, raised LDH, raised reticulocytes | Compensated hemolytic anemia | Correlate with peripheral smear and Coombs test to establish mechanism |
| Spherocytes on smear, increased osmotic fragility, negative Coombs | Hereditary spherocytosis | Consider splenectomy in symptomatic/severe cases; folate supplementation |
| Positive Ham test, negative Coombs, episodic hemoglobinuria | Paroxysmal nocturnal hemoglobinuria | Confirm with flow cytometry; screen for associated aplastic anemia |
Common Errors & How to Avoid Them
Cause: Spherocytes on a peripheral smear can result from either hereditary spherocytosis or autoimmune hemolytic anemia, and these have very different management pathways.
Prevention: Always perform a direct Coombs test alongside osmotic fragility testing before concluding a diagnosis.
Cause: The Ham test requires fresh complement activity; an old or improperly stored sample can give a false-negative result even in true PNH.
Prevention: Use fresh serum and process the Ham test promptly according to the standard protocol.
Cause: Hemosiderinuria may be overlooked if urine is not specifically stained for iron, delaying recognition of ongoing intravascular hemolysis.
Prevention: Perform a Prussian blue stain on urine sediment when intravascular hemolysis is suspected clinically.
Laboratory Tips from the Bench
A raised reticulocyte count with a raised unconjugated bilirubin and normal or low haptoglobin is one of the most reliable combined signatures of active hemolysis in the laboratory.
Flow cytometry for GPI-anchored proteins (CD55/CD59) has largely replaced the older Ham test as the gold-standard diagnostic test for PNH due to its greater sensitivity and specificity.
Remember 'Spleen eats sphere': spherocytes lose their flexibility and get trapped and destroyed by the spleen, which is why splenectomy is an effective treatment for hereditary spherocytosis.
Important Notes
Patients diagnosed with PNH should always be evaluated for coexisting or evolving aplastic anemia, as the two conditions are closely linked in their underlying clonal stem cell pathology.
The presence of hemosiderin in urine specifically indicates intravascular hemolysis has occurred recently enough for renal tubular cells to have reabsorbed and stored the iron — a useful timing clue in the work-up.
Interactive Quiz
Test Your KnowledgeFlashcards
Tap to flipClick or tap any card to reveal the answer. Use arrow keys to navigate in single-card mode.
Clinical Case Study
Apply Your KnowledgePresents with recurrent episodes of mild jaundice since childhood and known splenomegaly. His father had gallstones removed at age 25. No history of blood transfusion or recent medication use.
The combination of chronic mild hemolysis, spherocytes with an increased MCHC, a negative Coombs test, and a strong family history strongly supports an inherited red cell membrane defect rather than an acquired immune process.
- →A negative direct Coombs test is essential to exclude an autoimmune cause before diagnosing hereditary spherocytosis.
- →Family history is a valuable clue in autosomal dominant conditions like hereditary spherocytosis.
- →The osmotic fragility test provides objective confirmation of the membrane defect suspected on smear review.
Frequently Asked Questions
Intravascular hemolysis destroys red cells directly within the bloodstream, releasing free hemoglobin that can cause hemoglobinemia and hemoglobinuria, while extravascular hemolysis occurs when macrophages in the spleen, liver, or marrow phagocytose and destroy red cells, a process that does not release free hemoglobin into the plasma.
Since the spleen is the primary site where rigid, poorly deformable spherocytes are trapped and destroyed, removing the spleen significantly reduces red cell destruction and improves anemia, even though the underlying membrane defect remains present.
The classic nocturnal pattern is thought to relate to mild respiratory acidosis during sleep, which lowers blood pH slightly and further activates the complement system against the already complement-vulnerable PNH red cells.
Quick Revision
10-Minute ReviewKey Takeaways
- Hemolytic anemia results from increased red cell destruction exceeding marrow compensatory capacity.
- Classification by site (intravascular/extravascular) and mechanism (intracorpuscular/extracorpuscular) guides diagnosis.
- Biochemical hemolysis markers include raised bilirubin, raised LDH, reduced haptoglobin, and raised reticulocyte count.
- Hereditary spherocytosis is diagnosed by spherocyte morphology, increased osmotic fragility, and a negative Coombs test.
- PNH is an acquired clonal disorder diagnosed by the Ham test and, definitively, flow cytometry for GPI-anchored proteins.
- The direct Coombs test is the pivotal step distinguishing immune from non-immune causes of hemolysis.
Competency Checklist
Track Your MasteryReferences
- National Institute of Open Schooling. Hematology and Blood Bank Technique, Lesson 18: Hemolytic Anemia.
- Dacie JV, Lewis SM. Practical Haematology. 11th ed. Churchill Livingstone.
- Hoffbrand AV, Moss PAH. Essential Haematology. 7th ed. Wiley-Blackwell.